Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

<ul>
<li>Medicus Pharma Ltd. (TSXV:MDCX) is focused on acquiring or partnering with life-science companies that are developing novel therapeutics for unmet healthcare needs that are already in the clinical trial stage.</li>
<li>Management plans fast-track these specific therapies through FDA clinical trials toward commercialization.</li>
<li>The company's first acquisition was SkinJect, which has a novel, patented transdermal patch for the treatment of BCC.</li>
</ul>


Medicus Pharma Ltd. (TSXV:MDCX) is focused on acquiring or partnering with life-science companies that are developing novel therapeutics for unmet healthcare needs that are already in the clinical trial stage.
Management plans fast-track these specific therapies through FDA clinical trials toward commercialization.
The company's first acquisition was SkinJect, which has a novel, patented transdermal patch for the treatment of BCC.


V.MDCX: The Stock of Medicus Pharma Has Begun Trading on Nasdaq Under the Ticker MDCX

Medicus Pharma Ltd - The Stock of Medicus Pharma Has Begun Trading on Nasdaq Under the Ticker MDCX

Medicus Pharma Ltd. - Medicus Submits Updated Phase 2 Clinical Protocol

Canada

Medicus Pharma Ltd. is a clinical stage, multi-strategy holding company. The Company focuses on investing in and accelerating novel disruptive life sciences and bio-technology companies through FDA approved clinical trials. Medicus Pharma serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Medicus Pharma (MDPLF US)

V.MDCX: The Stock of Medicus Pharma Has Begun Trading on Nasdaq Under the Ticker MDCX

Medicus Pharma Ltd. (TSXV:MDCX) is focused on acquiring or partnering with life-science companies that are developing novel therapeutics for unmet...

Zacks Small Cap Research

Medicus Pharma Ltd - The Stock of Medicus Pharma Has Begun Trading on Nasdaq Under the Ticker MDCX

Medicus Pharma Ltd. (TSXV:MDCX) is focused on acquiring or partnering with life-science companies that are developing novel therapeutics for unmet...

Zacks Small Cap Research

Medicus Pharma Ltd. - Medicus Submits Updated Phase 2 Clinical Protocol

Management plans fast-track these specific therapies through FDA clinical trials toward commercialization. The company's first acquisition was SkinJec

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)